AAPL vs. LLY: Apple vs. Eli Lilly Stock Comparison
How do Apple (AAPL) and Eli Lilly (LLY) stack up? This page sets them side by side across company profile, performance and risk, profitability, growth, financial strength, dividends, and valuation, with selected fundamentals also measured against each stock's industry-group peers.
Company Profile
Apple (AAPL) is classified in the Information Technology sector (Technology Hardware & Equipment), whereas Eli Lilly (LLY) belongs to Health Care (Pharmaceuticals, Biotechnology & Life Sciences) — their GICS classifications point to very different parts of the market.
| Profile Item | AAPL | LLY |
|---|---|---|
| Name | Apple Inc. | Eli Lilly and Company |
| Country/Region | United States | United States |
| GICS Sector | Information Technology | Health Care |
| GICS Industry Group | Technology Hardware & Equipment | Pharmaceuticals, Biotechnology & Life Sciences |
| GICS Industry | Technology Hardware, Storage & Peripherals | Pharmaceuticals |
| GICS Sub-Industry | Technology Hardware, Storage & Peripherals | Pharmaceuticals |
| Market Capitalization | 4,975.38 billion USD | 1,206.07 billion USD |
| Currency | USD | USD |
| Exchange | Nasdaq | NYSE |
| Listing Date | December 12, 1980 | June 1, 1972 |
| Security Type | Common Stock | Common Stock |
Price Performance
Cumulative Growth
Trailing Returns
Calendar-Year Returns
Performance Metrics
| Metric | AAPL | LLY |
|---|---|---|
| Total Return (1Y) | 31.02% | 52.36% |
| Total Return (3Y, Annualized) | 24.87% | 34.18% |
| Total Return (5Y, Annualized) | 18.93% | 41.08% |
Risk Profile
Drawdown History
Return Distribution
Risk Metrics
| Metric | AAPL | LLY |
|---|---|---|
| Volatility (1Y, Annualized) | 24.99% | 35.34% |
| Beta (5Y) | 1.08 | 0.40 |
| Max Drawdown (5Y) | -33.36% | -34.48% |
| Avg. Volume (3M) | 42.44M | 2.52M |
Risk-Adjusted Performance
Risk-Return Positioning
Risk-Adjusted Metrics
| Metric | AAPL | LLY |
|---|---|---|
| Sharpe Ratio (1Y) | 1.07 | 1.36 |
| Sortino Ratio (1Y) | 1.58 | 2.29 |
Profitability
ROE (TTM)
Both companies show strong equity returns, but Apple (AAPL) at 142.26% is the standout with ROE above its industry range; Eli Lilly (LLY) at 86.02% also sits in the top quartile.
AAPL
Technology Hardware & Equipment industry group
142.26%
- AAPL
- 142.26%
- Max
- 42.47%
- Q3
- 19.13%
- Median
- 11.00%
- Q1
- 1.63%
- Min
- -20.62%
LLY
Pharmaceuticals, Biotechnology & Life Sciences industry group
86.02%
- Max
- 109.18%
- LLY
- 86.02%
- Q3
- 6.23%
- Median
- -26.66%
- Q1
- -64.05%
- Min
- -167.77%
Net Margin (TTM)
Eli Lilly (LLY) at 31.90% keeps the most of each sales dollar — above its industry’s net margin range — and Apple (AAPL) at 27.60% also retains a top-quartile share.
AAPL
Technology Hardware & Equipment industry group
27.60%
- AAPL
- 27.60%
- Max
- 27.60%
- Q3
- 11.66%
- Median
- 4.08%
- Q1
- 0.00%
- Min
- -11.02%
LLY
Pharmaceuticals, Biotechnology & Life Sciences industry group
31.90%
- LLY
- 31.90%
- Max
- 18.05%
- Q3
- 4.78%
- Median
- 0.00%
- Q1
- -4.14%
- Min
- -17.05%
Operating Margin (TTM)
Both Apple (AAPL) at 31.13% and Eli Lilly (LLY) at 53.66% convert sales into operating profit at a top-quartile rate, pointing to tighter cost discipline before financing and tax.
AAPL
Technology Hardware & Equipment industry group
31.13%
- Max
- 36.27%
- AAPL
- 31.13%
- Q3
- 18.36%
- Median
- 8.84%
- Q1
- 1.46%
- Min
- -21.39%
LLY
Pharmaceuticals, Biotechnology & Life Sciences industry group
53.66%
- Max
- 83.12%
- LLY
- 53.66%
- Q3
- 14.77%
- Median
- 0.00%
- Q1
- -78.82%
- Min
- -207.40%
Profitability Metrics
| Metric | AAPL | LLY |
|---|---|---|
| ROE (TTM) | 142.26% | 86.02% |
| ROA (TTM) | 25.87% | 21.06% |
| Net Margin (TTM) | 27.60% | 31.90% |
| Operating Margin (TTM) | 31.13% | 53.66% |
| Gross Margin (TTM) | 48.79% | 83.63% |
Growth
Revenue Growth
Both Apple (AAPL) at 15.06% and Eli Lilly (LLY) at 44.70% land near their industries' usual revenue growth ranges, so top-line momentum looks broadly in line with peers on both sides.
EPS Growth
Eli Lilly (LLY) at 95.99% sits in the top EPS growth quartile, while Apple (AAPL) at 20.38% is closer to the peer norm — faster per-share earnings growth for LLY.
Growth Metrics
| Metric | AAPL | LLY |
|---|---|---|
| Revenue Growth (YoY) | 15.06% | 44.70% |
| Revenue Growth (3Y CAGR) | 7.70% | 31.69% |
| EPS Growth (YoY) | 20.38% | 95.99% |
| EPS Growth (3Y CAGR) | 13.57% | 51.71% |
Financial Strength
Current Ratio (MRQ)
Both Apple (AAPL) at 1.02 and Eli Lilly (LLY) at 1.39 run current ratio in the tighter-liquidity quartile of industry peers, leaving thinner cushions against current liabilities than typical competitors.
AAPL
Technology Hardware & Equipment industry group
1.02
- Max
- 5.34
- Q3
- 3.02
- Median
- 1.95
- Q1
- 1.32
- AAPL
- 1.02
- Min
- 0.17
LLY
Pharmaceuticals, Biotechnology & Life Sciences industry group
1.39
- Max
- 25.13
- Q3
- 12.13
- Median
- 5.52
- Q1
- 2.47
- LLY
- 1.39
- Min
- 0.10
Debt / Equity (MRQ)
Both Apple (AAPL) at 0.84 and Eli Lilly (LLY) at 1.23 lean more heavily on debt funding than most peers, landing in the higher-leverage quartile of their industries.
AAPL
Technology Hardware & Equipment industry group
0.84
- Max
- 1.76
- AAPL
- 0.84
- Q3
- 0.78
- Median
- 0.24
- Q1
- 0.04
- Min
- 0.01
LLY
Pharmaceuticals, Biotechnology & Life Sciences industry group
1.23
- Max
- 1.42
- LLY
- 1.23
- Q3
- 0.65
- Median
- 0.15
- Q1
- 0.02
- Min
- 0.00
Financial Strength Metrics
| Metric | AAPL | LLY |
|---|---|---|
| Current Ratio (MRQ) | 1.02 | 1.39 |
| Debt / Equity (MRQ) | 0.84 | 1.23 |
| Net Debt / EBITDA | 0.22 | 0.96 |
Dividends
Dividend Yield (TTM)
Apple (AAPL) at 0.31% pays an industry-typical yield; Eli Lilly (LLY) at 0.49% is above its entire peer range — the higher number, but one that calls for a look at payout sustainability before treating it as an advantage.
AAPL
Technology Hardware & Equipment industry group
0.31%
- Max
- 0.73%
- Q3
- 0.31%
- AAPL
- 0.31%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
LLY
Pharmaceuticals, Biotechnology & Life Sciences industry group
0.49%
- LLY
- 0.49%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
Dividend Payout Ratio (TTM)
Apple (AAPL) at 11.80% keeps its payout in the industry’s typical band, while Eli Lilly (LLY) at 21.71% pays out more than any of its peers — the most stretched cover in its group.
AAPL
Technology Hardware & Equipment industry group
11.80%
- Max
- 32.27%
- Q3
- 14.48%
- AAPL
- 11.80%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
LLY
Pharmaceuticals, Biotechnology & Life Sciences industry group
21.71%
- LLY
- 21.71%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
Dividend Metrics
| Metric | AAPL | LLY |
|---|---|---|
| Dividend Yield (TTM) | 0.31% | 0.49% |
| Dividend Payout Ratio (TTM) | 11.80% | 21.71% |
Valuation
P/E Ratio (TTM)
Apple (AAPL) at 38.13 is near its industry’s usual P/E ratio, while Eli Lilly (LLY) at 43.95 sits in the richer quartile — LLY needs stronger growth or earnings quality to justify the premium.
AAPL
Technology Hardware & Equipment industry group
38.13
- Max
- 69.48
- Q3
- 41.02
- AAPL
- 38.13
- Median
- 26.39
- Q1
- 19.36
- Min
- 6.07
LLY
Pharmaceuticals, Biotechnology & Life Sciences industry group
43.95
- Max
- 85.34
- LLY
- 43.95
- Q3
- 43.46
- Median
- 26.69
- Q1
- 13.30
- Min
- 0.07
P/S Ratio (TTM)
Eli Lilly (LLY) at 13.95 is priced about in line with its industry on P/S ratio, while Apple (AAPL) at 10.39 sits in the pricier quartile — AAPL costs more per dollar of sales.
AAPL
Technology Hardware & Equipment industry group
10.39
- Max
- 11.30
- AAPL
- 10.39
- Q3
- 5.82
- Median
- 2.56
- Q1
- 1.05
- Min
- 0.00
LLY
Pharmaceuticals, Biotechnology & Life Sciences industry group
13.95
- Max
- 58.18
- Q3
- 25.77
- LLY
- 13.95
- Median
- 7.30
- Q1
- 3.01
- Min
- 0.01
P/B Ratio (MRQ)
Measured against book value, both Apple (AAPL) at 44.39 and Eli Lilly (LLY) at 29.96 look expensive — each P/B ratio sits above its industry’s benchmark range.
AAPL
Technology Hardware & Equipment industry group
44.39
- AAPL
- 44.39
- Max
- 10.75
- Q3
- 5.52
- Median
- 3.17
- Q1
- 1.79
- Min
- 0.33
LLY
Pharmaceuticals, Biotechnology & Life Sciences industry group
29.96
- LLY
- 29.96
- Max
- 13.53
- Q3
- 6.54
- Median
- 3.25
- Q1
- 1.69
- Min
- -5.59
Valuation Metrics
| Metric | AAPL | LLY |
|---|---|---|
| P/E Ratio (TTM) | 38.13 | 43.95 |
| P/S Ratio (TTM) | 10.39 | 13.95 |
| P/B Ratio (MRQ) | 44.39 | 29.96 |
| Free Cash Flow Yield (TTM) | 2.12% | 0.77% |